Back to Search

NRXP

NRX Pharmaceuticals, Inc. Common Stock
Data: 2026-07-31
$3.15
Price
0.96%
Change
$5.06
52W High
$1.62
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Quick Stats
Jul 31, 2026

57.1

AI Score

HOLD

1.25

Volume Ratio

Aug 17, 2026

Next Earnings

14

+ve Days (30d)

15

-ve Days (30d)

NRXP Stock Summary

Last updated Jul 31, 2026

NRXP is currently trading at $3.15, positioned above its 200-day moving average of $2.78, indicating a long-term uptrend. The stock has a 52-week range of $1.62 to $5.055.

Technical Analysis: The 50-day moving average stands at $3.95, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.112, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.092, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NRXP at 57.1/100 with a HOLD recommendation.

NRXP (NRX Pharmaceuticals, Inc. Common Stock) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 33.112
CMF (20) 0.092
ROC (10) -26.23
ADX (14) 19.864
Indicator Value
MACD (12,26,9) -0.16
AROONOSC (14) -42.857
WILLAMS %R (14) -81.868
MFI (14) 38.472
NRXP Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NRXP Price vs Max Options Open Interest
NRXP Max Change In Options Open Interest

NRXP Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NRXP Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NRXP Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NRXP Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

NRX Pharmaceuticals, Inc. Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

NRXP Moving Averages Analysis

NRX Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

NRXP (NRX Pharmaceuticals, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 3.76
20 3.97
30 3.92
50 3.95
100 3.24
200 2.78

NRXP Fundamental Analysis

P/E (Forward) 34.2466
P/E (Trailing) --
Market Cap ($) 133.5 million
Earnings/Share ($) -1
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.36
EPS Estimate Next Year ($) 0.5
WallStreet Target Price ($) 42.00
Most Recent Quarter